No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs16893079 |
chr8:125627924-125627925 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs147515154 |
chr8:125627925-125627926 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs62530670 |
chr8:125627950-125627951 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
4 |
rs113735498 |
chr8:125627970-125627971 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs564901932 |
chr8:125627971-125627972 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs564536682 |
chr8:125627977-125627978 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs527326928 |
chr8:125627995-125627996 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs371672287 |
chr8:125628012-125628013 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs542098535 |
chr8:125628116-125628117 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs560597331 |
chr8:125628157-125628158 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs148569578 |
chr8:125628173-125628174 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs147060389 |
chr8:125628191-125628192 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs113524375 |
chr8:125628195-125628196 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs535984435 |
chr8:125628236-125628237 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs3110541 |
chr8:125628285-125628286 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs549911842 |
chr8:125628293-125628294 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs546031435 |
chr8:125628310-125628311 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs538923983 |
chr8:125628311-125628312 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs558936407 |
chr8:125628320-125628321 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs72714747 |
chr8:125628336-125628337 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
21 |
rs16899858 |
chr8:125628342-125628343 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
22 |
rs554231900 |
chr8:125628358-125628359 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs141994885 |
chr8:125628376-125628377 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs542765133 |
chr8:125628404-125628405 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs3110542 |
chr8:125628409-125628410 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs3110543 |
chr8:125628418-125628419 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs3110544 |
chr8:125628421-125628422 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs563052121 |
chr8:125628423-125628424 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs3110545 |
chr8:125628430-125628431 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
30 |
rs545673591 |
chr8:125628438-125628439 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs78823505 |
chr8:125628472-125628473 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs11994513 |
chr8:125628486-125628487 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
33 |
rs546958177 |
chr8:125628539-125628540 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs375237895 |
chr8:125628542-125628543 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs114531105 |
chr8:125628556-125628557 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs4871516 |
chr8:125628599-125628600 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
37 |
rs550737877 |
chr8:125628613-125628614 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs76723839 |
chr8:125628615-125628616 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs75442619 |
chr8:125628616-125628617 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs112058822 |
chr8:125628629-125628630 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs560138280 |
chr8:125628635-125628636 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs398009755 |
chr8:125628636-125628637 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs569826664 |
chr8:125628647-125628648 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs141833533 |
chr8:125628666-125628667 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs11994520 |
chr8:125628685-125628686 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
46 |
rs76300961 |
chr8:125628686-125628687 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs565953698 |
chr8:125628693-125628694 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs34038975 |
chr8:125628705-125628706 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs566610372 |
chr8:125628724-125628725 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs71576743 |
chr8:125628770-125628771 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|